|
|
| Model Number |
VCP496G |
| Medical Device Problem Code |
Material Separation (1562)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/13/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
(b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.(b)(4).The product upon which this medwatch is based has been received, however, the product evaluation is not yet complete.Any further information derived from the evaluation will be submitted in a supplemental 3500a form.Additional information was requested and the following was obtained: please provide the lot number: unknown.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 275 g/m.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a c-section on (b)(6) 2022 and suture was used.During the procedure, the needle popped off the suture.It was retrieved.A new suture was used to complete the case with no patient consequences.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Product complaint # (b)(4) date sent to the fda: 7/11/2022 this is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: d9, h3, h6 h3 investigational summary: a paper lid, an empty winding former, and a detached needle of product code vcp496g were returned to ethicon inc for analysis.In order to evaluate the conditions of the returned sample, the swage and attachment area was as expected, the remnant of the suture was noted into the barrel hole, and marks were observed on the edge of the needle that was possibly caused by a surgical instrument.In addition, the suture was not received.The manufacturing records couldn't be reviewed as the batch number is unknown.The condition of the sample received indicates improper handling of the device.It should be noted that as part of our quality process, each batch is randomly inspected and functionally tested during manufacturing to ensure the device meets the required specifications prior to shipment.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Trade name - irgacare active ingredient(s)- triclosan dosage form - suture/solid/parenteral strength -= 275 g /m.
|
| |
|
Search Alerts/Recalls
|
|
|